These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 7687637)
1. Neutralization and infection-enhancement epitopes of influenza A virus hemagglutinin. Tamura M; Webster RG; Ennis FA J Immunol; 1993 Aug; 151(3):1731-8. PubMed ID: 7687637 [TBL] [Abstract][Full Text] [Related]
2. An analysis of the properties of monoclonal antibodies directed to epitopes on influenza virus hemagglutinin. Brown LE; Murray JM; White DO; Jackson DC Arch Virol; 1990; 114(1-2):1-26. PubMed ID: 1699509 [TBL] [Abstract][Full Text] [Related]
3. Immunodominance with progenitor B cell diversity in the neutralizing antibody repertoire to influenza infection. Patera AC; Graham CM; Thomas DB; Smith CA Eur J Immunol; 1995 Jul; 25(7):1803-9. PubMed ID: 7621857 [TBL] [Abstract][Full Text] [Related]
4. Neutralization escape mutants of type A influenza virus are readily selected by antisera from mice immunized with whole virus: a possible mechanism for antigenic drift. Lambkin R; McLain L; Jones SE; Aldridge SL; Dimmock NJ J Gen Virol; 1994 Dec; 75 ( Pt 12)():3493-502. PubMed ID: 7527838 [TBL] [Abstract][Full Text] [Related]
5. Broadly cross-reactive monoclonal antibodies against HA2 glycopeptide of Influenza A virus hemagglutinin of H3 subtype reduce replication of influenza A viruses of human and avian origin. Stropkovská A; Mucha V; Fislová T; Gocník M; Kostolanský F; Varecková E Acta Virol; 2009; 53(1):15-20. PubMed ID: 19301946 [TBL] [Abstract][Full Text] [Related]
6. A fairly conserved epitope on the hemagglutinin of influenza A (H3N2) virus with variable accessibility to neutralizing antibody. Vanlandschoot P; Beirnaert E; Dewilde S; Saelens X; Bestebroer T; De Jong J; Jou WM; Fiers W Virology; 1995 Oct; 212(2):526-34. PubMed ID: 7571422 [TBL] [Abstract][Full Text] [Related]
7. Epitopes of an influenza viral peptide recognized by antibody at single amino acid resolution. Schoofs PG; Geysen HM; Jackson DC; Brown LE; Tang XL; White DO J Immunol; 1988 Jan; 140(2):611-6. PubMed ID: 2447184 [TBL] [Abstract][Full Text] [Related]
8. Mutational analysis of a neutralization epitope on the dengue type 2 virus (DEN2) envelope protein: monoclonal antibody resistant DEN2/DEN4 chimeras exhibit reduced mouse neurovirulence. Hiramatsu K; Tadano M; Men R; Lai CJ Virology; 1996 Oct; 224(2):437-45. PubMed ID: 8874504 [TBL] [Abstract][Full Text] [Related]
9. [Antigenic structure of influenza A virus subtype H5 hemagglutinin: mechanism of acquiring stability to monoclonal antibodies in escape-mutants]. Il'iushina NA; Rudneva IA; Varich NL; Lipatov AS; Webster RG; Kaverin NV Mol Gen Mikrobiol Virusol; 2003; (1):40-5. PubMed ID: 12656046 [TBL] [Abstract][Full Text] [Related]
10. Characterization of the murine TH response to influenza virus hemagglutinin: evidence for three major specificities. Hurwitz JL; Herber-Katz E; Hackett CJ; Gerhard W J Immunol; 1984 Dec; 133(6):3371-7. PubMed ID: 6208279 [TBL] [Abstract][Full Text] [Related]
11. An epitope shared by the hemagglutinins of H1, H2, H5, and H6 subtypes of influenza A virus. Smirnov YA; Lipatov AS; Gitelman AK; Okuno Y; Van Beek R; Osterhaus AD; Claas EC Acta Virol; 1999 Aug; 43(4):237-44. PubMed ID: 10749369 [TBL] [Abstract][Full Text] [Related]
12. Different neutralization efficiency of neutralizing monoclonal antibodies against avian influenza H5N1 virus to virus strains from different hosts. Huang H; Dan H; Zhou Y; Yu Z; Fan H; Tong T; Jin M; Chen H Mol Immunol; 2007 Feb; 44(5):1052-5. PubMed ID: 16965815 [TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies to glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin. Russ G; Poláková K; Kostolanský F; Styk B; Vancíková M Acta Virol; 1987 Sep; 31(5):374-86. PubMed ID: 2891276 [TBL] [Abstract][Full Text] [Related]
14. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus. Gromowski GD; Barrett AD Virology; 2007 Sep; 366(2):349-60. PubMed ID: 17719070 [TBL] [Abstract][Full Text] [Related]
15. Structural assignment of novel and immunodominant antigenic sites in the neutralizing antibody response of CBA/Ca mice to influenza hemagglutinin. Smith CA; Barnett BC; Thomas DB; Temoltzin-Palacios F J Exp Med; 1991 Apr; 173(4):953-9. PubMed ID: 1706753 [TBL] [Abstract][Full Text] [Related]
16. HA2-specific monoclonal antibodies as tools for differential recognition of influenza A virus antigenic subtypes. Varecková E; Mucha V; Kostolanský F; Gubareva LV; Klimov A Virus Res; 2008 Mar; 132(1-2):181-6. PubMed ID: 18037184 [TBL] [Abstract][Full Text] [Related]
17. Competitive binding of neutralizing monoclonal and polyclonal IgG to the HA of influenza A virions in solution: only one IgG molecule is bound per HA trimer regardless of the specificity of the competitor. Taylor HP; Dimmock NJ Virology; 1994 Nov; 205(1):360-3. PubMed ID: 7975232 [TBL] [Abstract][Full Text] [Related]
18. Conserved determinants for CD4+ T cells within the light chain of the H3 hemagglutinin molecule of influenza virus. Jackson DC; Drummer HE; Brown LE Virology; 1994 Feb; 198(2):613-23. PubMed ID: 7507281 [TBL] [Abstract][Full Text] [Related]
19. A monoclonal antibody specific to the HA2 glycoprotein of influenza A virus hemagglutinin that inhibits its fusion activity reduces replication of the virus. Varecková E; Wharton SA; Mucha V; Gocník M; Kostolanský F Acta Virol; 2003; 47(4):229-36. PubMed ID: 15068378 [TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody mapping of the envelope glycoprotein of the dengue 2 virus, Jamaica. Roehrig JT; Bolin RA; Kelly RG Virology; 1998 Jul; 246(2):317-28. PubMed ID: 9657950 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]